Precision BioSciences (DTIL) vs TRex Bio (TRXB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
TRex Bio is the larger company by market cap ($297.0 million vs $282.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DTIL | TRXB |
|---|---|---|
| Share price | $7.40 | $10.32 |
| Market cap | $282.46M | $296.95M |
| 1-day change | +7.09% | +6.12% |
| YTD return | +77.88% | — |
| 1-year return | +48.00% | — |
| 5-year return | -97.23% | — |
| P/E ratio (TTM) | 29.60 | — |
| EPS (TTM) | $0.25 | $-2.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $34.26M | — |
| Revenue growth (YoY) | -50.12% | — |
| Net income (latest FY) | $-45.72M | — |
| Operating margin | -152.19% | — |
| Net margin | -133.45% | — |
| 52-week high | $11.29 | $16.56 |
| 52-week low | $3.53 | $9.06 |
| Distance from 52-week high | -34.46% | -37.71% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +297.30% | +183.57% |
| Average volume | 319.79K | 156.80K |
| Shares outstanding | 38.17M | 28.79M |
| Employees | 69 | 60 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Precision BioSciences
DTIL stock →Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 69 employees
About TRex Bio
TRXB stock →TRex Bio, Inc. develops immunoregulatory biologics for autoimmune and inflammatory diseases in United States and Internationally.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 60 employees
DTIL vs TRXB FAQ
Which is bigger, Precision BioSciences or TRex Bio?
TRex Bio (TRXB) is larger, with a market capitalization of $296.95M compared with $282.46M for Precision BioSciences (DTIL).
Are Precision BioSciences and TRex Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.